{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T13:07:06Z","timestamp":1779541626362,"version":"3.53.1"},"reference-count":55,"publisher":"Central Research Institute for Epidemiology","issue":"2","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["virusjour.crie.ru"],"crossmark-restriction":false},"short-container-title":["Problems of Virology"],"abstract":"<jats:p>Introduction. The spread of tick-borne encephalitis virus (Orthoflavivirus encephalitidis) continues. Existing vaccines have several limitations. Research new vaccine platforms will enable the development of more effective strategies of disease prevention.\r\nMaterials and methods. The constructs for producing vaccine preparations were obtained using the methods described earlier. Study of the effectiveness of candidate vaccines based on chimeric yellow fever virus, adenovirus serotype 25 and mRNA encoding a fragment of the tick-borne encephalitis viral polyprotein corresponding to the PrM and E regions, immunogenicity and protective efficacy was performed using BALB\/c mice. The neutralizing activity assessment of animal sera and mice challenge were performed using the tick-borne encephalitis virus strain Sofjin-Chumakov.\r\nResults. It was established that immunization of animals with mRNA encoding the PrM and E regions of the viral polyprotein of tick-borne encephalitis virus resulted in the induction of a higher level of neutralizing antibodies compared to the other vaccine platforms studied in the immunization schedule used. In addition, this platform provided 100% protection of animals from the lethal infection caused by the tick-borne encephalitis virus.\r\nConclusion. The study demonstrated that delivery of the nucleotide sequence encoding the PrM and E regions of the tick-borne encephalitis virus polyprotein within mRNA elicits a pronounced humoral immune response during animal immunization. These results demonstrate the fundamental feasibility of effectively expressing the same tick-borne encephalitis virus antigen in various vaccine platforms, each with its own advantages and limitations.<\/jats:p>","DOI":"10.36233\/0507-4088-353","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:12:15Z","timestamp":1778429535000},"page":"109-126","update-policy":"https:\/\/doi.org\/10.36233\/0372-9311-crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain"],"prefix":"10.36233","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-2059","authenticated-orcid":false,"given":"Andrei E.","family":"Siniavin","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"},{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9397-3762","authenticated-orcid":false,"given":"Vladimir A.","family":"Gushchin","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"},{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences"},{"name":"Lomonosov Moscow State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-7628","authenticated-orcid":false,"given":"Nadezhda A.","family":"Kuznetsova","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6353-9917","authenticated-orcid":false,"given":"Leonid I.","family":"Russu","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5470-4917","authenticated-orcid":false,"given":"Elizaveta V.","family":"Marchuk","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-7238","authenticated-orcid":false,"given":"Denis A.","family":"Kleymenov","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5823-6508","authenticated-orcid":false,"given":"Maria A.","family":"Nikiforova","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7893-8419","authenticated-orcid":false,"given":"Olga V.","family":"Zubkova","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"},{"name":"P. Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiology Center, Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3248-1227","authenticated-orcid":false,"given":"Olga D.","family":"Popova","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6272-0368","authenticated-orcid":false,"given":"Irina V.","family":"Vavilova","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-1553","authenticated-orcid":false,"given":"Tatiana A.","family":"Ozharovskaia","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0701-5152","authenticated-orcid":false,"given":"Elena P.","family":"Mazunina","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2269-1469","authenticated-orcid":false,"given":"Evgeniia N.","family":"Bykonia","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8199-6417","authenticated-orcid":false,"given":"Elena V.","family":"Shidlovskaya","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-2465","authenticated-orcid":false,"given":"Evgeny V.","family":"Usachev","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8133-1036","authenticated-orcid":false,"given":"Olga V.","family":"Usacheva","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-9351","authenticated-orcid":false,"given":"Andrey A.","family":"Pochtovyi","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"},{"name":"I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0164-5113","authenticated-orcid":false,"given":"Vladimir I.","family":"Zlobin","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4035-6581","authenticated-orcid":false,"given":"Denis Y.","family":"Logunov","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1769-5059","authenticated-orcid":false,"given":"Alexander L.","family":"Gintsburg","sequence":"additional","affiliation":[{"name":"National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation"},{"name":"I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22004","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Ruzek D., Av\u0161i\u010d \u017dupanc T., Borde J., Chrdle A., Eyer L., Karganova G., et al. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res. 2019; 164: 23\u201351. https:\/\/doi.org\/10.1016\/j.antiviral.2019.01.014","DOI":"10.1016\/j.antiviral.2019.01.014"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Kovalev S., Mukhacheva A. Reconsidering the classification of tick-borne encephalitis virus within the Siberian subtype gives new insights into its evolutionary history. Infect. Genet. Evol. 2017; 55: 159\u201365. https:\/\/doi.org\/10.1016\/j.meegid.2017.09.014","DOI":"10.1016\/j.meegid.2017.09.014"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Dai X., Shang G., Lu S., Yang J., Xu J. A new subtype of eastern tick-borne encephalitis virus discovered in Qinghai-Tibet Plateau, China. Emerg. Microbes Infect. 2018; 7(1): 74. https:\/\/doi.org\/10.1038\/s41426-018-0081-6","DOI":"10.1038\/s41426-018-0081-6"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Bogovic P., Strle F. Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. World J. Clin. Cases. 2015; 3(5): 430\u201341. https:\/\/doi.org\/10.12998\/wjcc.v3.i5.430","DOI":"10.12998\/wjcc.v3.i5.430"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Dobler G., Gniel D., Petermann R., Pfeffer M. Epidemiology and distribution of tick-borne encephalitis. Wien. Med. Wochenschr. 2012; 162(11-12): 230\u20138. https:\/\/doi.org\/10.1007\/s10354-012-0100-5","DOI":"10.1007\/s10354-012-0100-5"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"P\u00f6llabauer E.M., Pavlova B.G., L\u00f6w-Baselli A., Fritsch S., Prymula R., Angermayr R., et al. Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine. 2010; 28(29): 4680\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.047","DOI":"10.1016\/j.vaccine.2010.04.047"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bestehorn-Willmann M., Girl P., Greiner F., Mackenstedt U., Dobler G., Lang D. Increased vaccination diversity leads to higher and less-variable neutralization of TBE viruses of the European subtype. Vaccines (Basel). 2023; 11(6): 1044. https:\/\/doi.org\/10.3390\/vaccines11061044","DOI":"10.3390\/vaccines11061044"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Leonova G.N., Pavlenko E.V. Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human. Vaccine. 2009; 27(21): 2899\u2013904. https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.069","DOI":"10.1016\/j.vaccine.2009.02.069"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lu Z., Br\u00f6ker M., Liang G. Tick-borne encephalitis in mainland China. Vector Borne Zoonotic Dis. 2008; 8(5): 713\u201320. https:\/\/doi.org\/10.1089\/vbz.2008.0028","DOI":"10.1089\/vbz.2008.0028"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kubinski M., Beicht J., Gerlach T., Volz A., Sutter G., Rimmelzwaan G.F. Tick-borne encephalitis virus: a quest for better vaccines against a virus on the rise. Vaccines (Basel). 2020; 8(3): 451. https:\/\/doi.org\/10.3390\/vaccines8030451","DOI":"10.3390\/vaccines8030451"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ghattas M., Dwivedi G., Lavertu M., Alameh M.G. Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities. Vaccines (Basel). 2021; 9(12): 1490. https:\/\/doi.org\/10.3390\/vaccines9121490","DOI":"10.3390\/vaccines9121490"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Pollard A., Bijker E. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol. 2021; 21(2): 83\u2013100. https:\/\/doi.org\/10.1038\/s41577-020-00479-7","DOI":"10.1038\/s41577-020-00479-7"},{"key":"ref13","unstructured":"Heinz F., Stiasny K. Chapter 2b: The molecular and antigenic structure of the TBEV. Global Health Press; 2016. Available at: https:\/\/tbenews.com\/tbe\/tbe2b\/"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Simmonds P., Becher P., Bukh J., Gould EA., Meyers G., Monath T., et al. ICTV virus taxonomy profile: flaviviridae. J. Gen. Virol. 2017; 98(1): 2\u20133. https:\/\/doi.org\/10.1099\/jgv.0.000672","DOI":"10.1099\/jgv.0.000672"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Pulkkinen L.I.A., Butcher S.J., Anastasina M. Tick-borne encephalitis virus: a structural view. Viruses. 2018; 10(7): 350. https:\/\/doi.org\/10.3390\/v10070350","DOI":"10.3390\/v10070350"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"F\u00fczik T., Formanov\u00e1 P., R\u016f\u017eek D., Yoshii K., Niedrig M., Plevka P. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody. Nat. Commun. 2018; 9(1): 436. https:\/\/doi.org\/10.1038\/s41467-018-02882-0","DOI":"10.1038\/s41467-018-02882-0"},{"key":"ref17","unstructured":"Maramorosch K., Chambers T.J., Shatkin A.J., Monath T.P., Murphy F.A., eds. The Flaviviruses: Structure, Replication and Evolution. 1st ed. Elsevier; 2003."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Kuznetsova N., Siniavin A., Butenko A., Larichev V., Kozlova A., Usachev E., et al. Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus. PLoS One. 2023; 18(5): e0284823. https:\/\/doi.org\/10.1371\/journal.pone.0284823","DOI":"10.1371\/journal.pone.0284823"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Guo W., Jiang T., Rao J., Zhang Z., Zhang X., Su J., et al. A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection. iScience. 2024; 27(10): 110972. https:\/\/doi.org\/10.1016\/j.isci.2024.110972","DOI":"10.1016\/j.isci.2024.110972"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ozharovskaia T.A., Popova O., Zubkova O.V., Vavilova I.V., Pochtovyy A.A., Shcheblyakov D.V., et al. Development and characterization of a vector system based on the simian adenovirus type 25. Bulletin of Russian State Medical University. 2023; (1): 4\u201311. https:\/\/doi.org\/10.24075\/brsmu.2023.006 https:\/\/elibrary.ru\/dkznse","DOI":"10.24075\/brsmu.2023.006"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Kanegae Y., Makimura M., Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 1994; 47(3): 157\u201366. https:\/\/doi.org\/10.7883\/yoken1952.47.157","DOI":"10.7883\/yoken1952.47.157"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259): 680\u20135. https:\/\/doi.org\/10.1038\/227680a0","DOI":"10.1038\/227680a0"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Panova E.A., Kleymenov D.A., Shcheblyakov D.V., Bykonia E.N., Mazunina E.P., Dzharullaeva A.S., et al. Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A. Front. Immunol. 2023; 14: 1098302. https:\/\/doi.org\/10.3389\/fimmu.2023.1098302","DOI":"10.3389\/fimmu.2023.1098302"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Mazunina E.P., Gushchin V.A., Kleymenov D.A., Siniavin A.E., Burtseva E.I., Shmarov M.M., et al. Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response. Front. Immunol. 2024; 15: 1381508. https:\/\/doi.org\/10.3389\/fimmu.2024.1381508","DOI":"10.3389\/fimmu.2024.1381508"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Mazunina E.P., Gushchin V.A., Bykonia E.N., Kleymenov D.A., Siniavin A.E., Kozlova S.R., et al. Immunogenicity and efficacy of combined mRNA vaccine against influenza and SARS-CoV-2 in mice animal models. Vaccines (Basel). 2024; 12(11): 1206. https:\/\/doi.org\/10.3390\/vaccines12111206","DOI":"10.3390\/vaccines12111206"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 1938; 27(3): 493\u20137. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a118408","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Hansson K.E., Rosdahl A., Insulander M., Vene S., Lindquist L., Gredmark-Russ S., et al. Tick-borne encephalitis vaccine failures: a 10-year retrospective study supporting the rationale for adding an extra priming dose in individuals starting at age 50 years. Clin. Infect. Dis. 2020; 70(2): 245\u201351. https:\/\/doi.org\/10.1093\/cid\/ciz176","DOI":"10.1093\/cid\/ciz176"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Dobler G., Kaier K., Hehn P., B\u00f6hmer M.M., Kreusch T.M., Borde J.P. Tick-borne encephalitis virus vaccination breakthrough infections in Germany: a retrospective analysis from 2001 to 2018. Clin. Microbiol. Infect. 2020; 26(8): 1090.e7\u201313. https:\/\/doi.org\/10.1016\/j.cmi.2019.12.001","DOI":"10.1016\/j.cmi.2019.12.001"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Gei\u00dflreiter B., Kluger G., Eschermann K., Kiwull L., Staudt M., Dobler G., et al. High neutralizing antibody mismatch as a possible reason for vaccine failure in two children with severe tick-borne encephalitis. Ticks Tick Borne Dis. 2023; 14(4): 102158. https:\/\/doi.org\/10.1016\/j.ttbdis.2023.102158","DOI":"10.1016\/j.ttbdis.2023.102158"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Tuchynskaya K., Volok V., Illarionova V., Okhezin E., Polienko A., Belova O., et al. Experimental assessment of possible factors associated with tick-borne encephalitis vaccine failure. Microorganisms. 2021; 9(6): 1172. https:\/\/doi.org\/10.3390\/microorganisms9061172","DOI":"10.3390\/microorganisms9061172"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Thomas S.J., Yoon I. A review of Dengvaxia\u00ae: development to deployment. Hum. Vaccin. Immunother. 2019; 15(10): 2295\u2013314. https:\/\/doi.org\/10.1080\/21645515.2019.1658503","DOI":"10.1080\/21645515.2019.1658503"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Chokephaibulkit K., Houillon G., Feroldi E., Bouckenooghe A. Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV\u00ae) in children. Expert. Rev. Vaccines. 2016; 15(2): 153\u201366. https:\/\/doi.org\/10.1586\/14760584.2016.1123097","DOI":"10.1586\/14760584.2016.1123097"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Pletnev A.G., Men R. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc. Natl Acad. Sci. USA. 1998; 95(4): 1746\u201351. https:\/\/doi.org\/10.1073\/pnas.95.4.1746","DOI":"10.1073\/pnas.95.4.1746"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Pletnev A.G., Karganova G.G., Dzhivanyan T.I., Lashkevich V.A., Bray M. Chimeric Langat\/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. Virology. 2000; 274(1): 26\u201331. https:\/\/doi.org\/10.1006\/viro.2000.0426","DOI":"10.1006\/viro.2000.0426"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Wang H.J., Li X.F., Ye Q., Li S.H., Deng Y.Q., Zhao H., et al. Recombinant chimeric Japanese encephalitis virus\/tick-borne encephalitis virus is attenuated and protective in mice. Vaccine. 2014; 32(8): 949\u201356. https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.050","DOI":"10.1016\/j.vaccine.2013.12.050"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Lee C.S., Bishop E.S., Zhang R., Yu X., Farina E.M., Yan S., et al. Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes Dis. 2017; 4(2): 43\u201363. https:\/\/doi.org\/10.1016\/j.gendis.2017.04.001","DOI":"10.1016\/j.gendis.2017.04.001"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Appaiahgari M.B., Vrati S. Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls. Expert Opin. Biol. Ther. 2015; 15(3): 337\u201351. https:\/\/doi.org\/10.1517\/14712598.2015.993374","DOI":"10.1517\/14712598.2015.993374"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Tatsis N., Ertl H.\u0421\u044e Adenoviruses as vaccine vectors. Mol. Ther. 2004; 10(4): 616\u201329. https:\/\/doi.org\/10.1016\/j.ymthe.2004.07.013","DOI":"10.1016\/j.ymthe.2004.07.013"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Dussupt V., Sankhala R.S., Gromowski G.D., Donofrio G., De La Barrera R.A., Larocca R.A., et al. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor. Nat. Med. 2020; 26(2): 228\u201335. https:\/\/doi.org\/10.1038\/s41591-019-0746-2","DOI":"10.1038\/s41591-019-0746-2"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Vrba S., Kirk N.M., Brisse M.E., Liang Y., Ly H. Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats. Vaccines (Basel). 2020; 8(4): 680. https:\/\/doi.org\/10.3390\/vaccines8040680","DOI":"10.3390\/vaccines8040680"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Jacobs S.C., Stephenson J.R., Wilkinson G.W. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J. Virol. 1992; 66(4): 2086\u201395. https:\/\/doi.org\/10.1128\/JVI.66.4.2086-2095.1992","DOI":"10.1128\/jvi.66.4.2086-2095.1992"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Jacobs S.C., Stephenson J.R., Wilkinson G.W. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. J. Gen. Virol. 1994; 75(Pt. 9): 2399\u2013402. https:\/\/doi.org\/10.1099\/0022-1317-75-9-2399","DOI":"10.1099\/0022-1317-75-9-2399"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Timofeev A.V., Ozherelkov S.V., Pronin A.V., Deeva A.V., Karganova G.G., Elbert L.B., et al. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein. J. Gen. Virol. 1998; 79(Pt. 4): 689\u201395. https:\/\/doi.org\/10.1099\/0022-1317-79-4-689","DOI":"10.1099\/0022-1317-79-4-689"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Pollard C., De Koker S., Saelens X., Vanham G., Grooten J. Challenges and advances towards the rational design of mRNA vaccines. Trends Mol. Med. 2013; 19(12): 705\u201313. https:\/\/doi.org\/10.1016\/j.molmed.2013.09.002","DOI":"10.1016\/j.molmed.2013.09.002"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Pardi N., Hogan M.J., Porter F.W., Weissman D. mRNA vaccines \u2013 a new era in vaccinology. Nat. Rev. Drug Discov. 2018; 17(4): 261\u201379. https:\/\/doi.org\/10.1038\/nrd.2017.243","DOI":"10.1038\/nrd.2017.243"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Bahl K., Senn J.J., Yuzhakov O., Bulychev A., Brito L.A., Hassett K.J., et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol. Ther. 2022; 30(8): 2874. https:\/\/doi.org\/10.1016\/j.ymthe.2022.07.013","DOI":"10.1016\/j.ymthe.2022.07.013"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Pardi N., LaBranche C.C., Ferrari G., Cain D.W., Tomb\u00e1cz I., Parks R.J., et al. Characterization of HIV-1 nucleoside-modified mRNA vaccines in rabbits and rhesus macaques. Mol. Ther. Nucleic Acids. 2019; 15: 36\u201347. https:\/\/doi.org\/10.1016\/j.omtn.2019.03.003","DOI":"10.1016\/j.omtn.2019.03.003"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Alberer M., Gnad-Vogt U., Hong H.S., Mehr K.T., Backert L., Finak G., et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet. 2017; 390(10101): 1511\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(17)31665-3","DOI":"10.1016\/S0140-6736(17)31665-3"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Kose N., Fox J.M., Sapparapu G., Bombardi R., Tennekoon R.N., de Silva A.D., et al. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection. Sci. Immunol. 2019; 4(35): eaaw6647. https:\/\/doi.org\/10.1126\/sciimmunol.aaw6647","DOI":"10.1126\/sciimmunol.aaw6647"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Nelson C.S., Jenks J.A., Pardi N., Goodwin M., Roark H., Edwards W., et al. Human cytomegalovirus glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization. J. Virol. 2020; 94(9): e00186-20. https:\/\/doi.org\/10.1128\/JVI.00186-20","DOI":"10.1128\/JVI.00186-20"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Zhang M., Sun J., Li M., Jin X. Modified mRNA-LNP vaccines confer protection against experimental DENV-2 infection in mice. Mol. Ther. Methods Clin. Dev. 2020; 18: 702\u201312. https:\/\/doi.org\/10.1016\/j.omtm.2020.07.013","DOI":"10.1016\/j.omtm.2020.07.013"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Essink B., Chu L., Seger W., Barranco E., Le Cam N., Bennett H., et al. The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials. Lancet Infect Dis. 2023; 23(5): 621\u201333. https:\/\/doi.org\/10.1016\/S1473-3099(22)00764-2","DOI":"10.1016\/S1473-3099(22)00764-2"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"VanBlargan L.A., Himansu S., Foreman B.M., Ebel G.D., Pierson T.C., Diamond M.S. An mRNA vaccine protects mice against multiple tick-transmitted flavivirus infections. Cell Rep. 2018; 25(12): 3382\u201392.e3. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.082","DOI":"10.1016\/j.celrep.2018.11.082"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Mulligan M.J., Lyke K.E., Kitchin N., Absalon J., Gurtman A., Lockhart S., et al. Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020; 586(7830): 589\u201393. https:\/\/doi.org\/10.1038\/s41586-020-2639-4","DOI":"10.1038\/s41586-020-2639-4"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Richner J.M., Himansu S., Dowd K.A., Butler S.L., Salazar V., Fox J.M., et al. Modified mRNA vaccines protect against Zika virus infection. Cell. 2017; 169(1): 176. https:\/\/doi.org\/10.1016\/j.cell.2017.03.016","DOI":"10.1016\/j.cell.2017.03.016"}],"container-title":["Problems of Virology"],"original-title":[],"link":[{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16815\/1090","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16815\/1090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:41:19Z","timestamp":1779540079000},"score":1,"resource":{"primary":{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/view\/16815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,8]]}},"URL":"https:\/\/doi.org\/10.36233\/0507-4088-353","relation":{},"ISSN":["2411-2097","0507-4088"],"issn-type":[{"value":"2411-2097","type":"electronic"},{"value":"0507-4088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}